Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Stuart G. Tangye, Lindsey B. Rosen et al.|Science|2020Cited by 2.9k
The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients’ survival and long COVIDMaddalena Noviello, Chiara Bonini, Claudia de Lalla et al.|Frontiers in Immunology|2024Cited by 12